Internal Medicine, Endocrinology, Diabetes, & Metabolism · Charleston, WV
NPI
1013947241
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1097 Fledderjohn Rd
Charleston, WV, 25314
Phone (304) 720-1963
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,317 services
Medicare patients, 2024
356
Average age 71
Drug cost, 2024
$4.0M
8,338 prescriptions
Company payments, 2025
$926
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samar R Sankari was code 99214 (office e&m - established), 577 times for 280 patients. In total Samar R Sankari billed 1,317 services in 8 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 577 | 280 | $70.54 | $41K |
| 95251 Test - Miscellaneous | Office | 309 | 122 | $26.56 | $8,207 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 260 | 34 | $37.99 | $9,876 |
| 99213 Office E&M - Established | Office | 83 | 76 | $43.98 | $3,650 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 51 | 18 | $26.65 | $1,359 |
| 99203 Office E&M - New | Office | 16 | 16 | $61.41 | $983 |
| 99204 Office E&M - New | Office | 11 | 11 | $106.61 | $1,173 |
By year: 2022 $95K for 2,007 services; 2023 $83K for 1,810 services; 2024 $67K for 1,317 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samar R Sankari prescribed most often to Medicare patients was Levothyroxine Sodium, with 929 prescriptions and refills. In total Samar R Sankari wrote 8,338 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 929 | 2,374 | 244 | $9,943 |
| Ozempic Semaglutide | 760 | 1,074 | 155 | $991K |
| Synthroid Levothyroxine Sodium | 708 | 1,747 | 166 | $69K |
| Jardiance Empagliflozin | 510 | 1,125 | 119 | $647K |
| Metformin Hcl Er Metformin Hcl | 401 | 1,033 | 121 | $7,554 |
| Novolog Flexpen Insulin Aspart | 340 | 618 | 121 | $121K |
| Mounjaro Tirzepatide | 280 | 350 | 47 | $369K |
| Atorvastatin Calcium Generic | 274 | 736 | 91 | $1,800 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 248 | 584 | 83 | $47K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 210 | 471 | 95 | $32K |
| Trulicity Dulaglutide | 205 | 318 | 47 | $305K |
| Metformin Hcl Generic | 176 | 430 | 46 | $962 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 174 | 393 | 50 | $199K |
| Glimepiride Generic | 170 | 501 | 52 | $1,112 |
| Tresiba Flextouch U-200 Insulin Degludec | 151 | 341 | 45 | $209K |
Brand drugs: 4,886 claims; generic drugs: 2,913 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samar R Sankari $926 ($926 in general payments such as food, travel and fees) from 11 companies. The largest payer was Dexcom, Inc. with $247.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 6 | $247 |
| Amgen Inc. AMGN | 9 | $236 |
| Novo Nordisk Inc NVO | 12 | $192 |
| Lilly USA, LLC LLY | 4 | $71.35 |
| Abbvie Inc. ABBV | 2 | $50.21 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $33.25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30.29 |
| Medtronic, Inc. MDT | 1 | $18.03 |
| Insulet Corporation PODD | 1 | $17.29 |
| Sequel Med Tech, LLC | 1 | $16.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.